Cargando…

Acute renal failure after treatment with sunitinib in a patient with multiple myeloma

Sunitinib is a multiple tyrosine kinase receptors inhibitor that is approved for the treatment of advanced renal cell carcinoma. Amongst its targets are fetal liver tyrosine kinase receptor 3 (FLT 3) and vascular endothelial growth factor receptor (VEGFR). Renal toxicity has not been reported from t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Nelson, Saucier, Nathan A., Zeldenrust, Steven R., Gunderson, Heidi D., Cornell, Lynn D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421250/ https://www.ncbi.nlm.nih.gov/pubmed/25984018 http://dx.doi.org/10.1093/ndtplus/sfp037

Ejemplares similares

Multiple myeloma presented as acute renal failure
por: Momeni, Ali, et al.
Publicado: (2013)

Nephrotic Syndrome and Acute Renal Failure Apparently Induced by Sunitinib
por: Chen, Ying-Shou, et al.
Publicado: (2009)

Sunitinib-Induced Acute Liver Failure
por: Aqsa, Anum, et al.
Publicado: (2021)

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
por: Gonsalves, W I, et al.
Publicado: (2015)

Multiple myeloma with acute light chain cast nephropathy
por: Leung, Nelson, et al.
Publicado: (2023)

Multiple Myeloma Presenting as Acute Renal Failure in the Absence of Other Characteristic Features
por: Gastelum, Zachary N, et al.
Publicado: (2017)

Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management
por: Kundu, Sumana, et al.
Publicado: (2022)

Multiple Myeloma Presenting as Acute Liver Failure
por: Cull, Stephanie, et al.
Publicado: (2017)

Sunitinib and other targeted therapies for renal cell carcinoma
por: Powles, T, et al.
Publicado: (2011)

Immunoglobulin D Multiple Myeloma With Rapidly Progressing Renal Failure
por: Modi, Jwalant, et al.
Publicado: (2015)

The Relationship between Multiple Myeloma with Renal Failure and Metastatic Calcification
por: Fukuta, Takanori, et al.
Publicado: (2018)

Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
por: Shah, Urvi A., et al.
Publicado: (2018)

New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies
por: Woziwodzka, Karolina, et al.
Publicado: (2020)

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib
por: Flaig, T W, et al.
Publicado: (2010)

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
por: Kumar, Shaji K., et al.
Publicado: (2013)

Biclonal myeloma in renal failure
por: NIKOLOVA-VLAHOVA, MILENA K., et al.
Publicado: (2020)

Sunitinib for advanced renal cell cancer
por: Coppin, Chris
Publicado: (2008)

Sunitinib resistance in renal cell carcinoma
por: Morais, Christudas
Publicado: (2014)

Pathogenesis of Renal Failure in Multiple Myeloma: Any Role of Contrast Media?
por: Mussap, Michele, et al.
Publicado: (2014)

A Study on Renal Failure Management in Patients Diagnosed With Multiple Myeloma
por: Almuhaysen, Lama M, et al.
Publicado: (2023)

A case of tumor lysis syndrome and acute renal failure associated with elotuzumab treatment in multiple myeloma
por: Atchison, Douglas K., et al.
Publicado: (2017)

Relapsing Extramedullary Multiple Myeloma Presenting As Acute Liver Failure
por: Javaid, Hafiza Wajeeha, et al.
Publicado: (2021)

Rapidly Progressive Acute Liver Failure in Relapsed Multiple Myeloma
por: Wadehra, Anshu, et al.
Publicado: (2020)

Autologous Stem Cell Transplantation in Multiple Myeloma with Renal Failure: Friend or Foe?
por: Zhong, Hongfei, et al.
Publicado: (2019)

A case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia
por: Leung, Nelson, et al.
Publicado: (2010)

Acute Acquired Fanconi Syndrome in Multiple Myeloma After Hematopoietic Stem Cell Transplantation
por: Sy-Go, Janina Paula T., et al.
Publicado: (2020)

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
por: Binder, M, et al.
Publicado: (2016)

Case Report on Renal Failure Reversal in Lambda Chain Multiple Myeloma with Bortezomib and Dexamethasone
por: Patibandla, Bhanu K., et al.
Publicado: (2014)

Hypercalcemia, Renal Failure, and Skull Lytic Lesions: Follicular Lymphoma Masquerading as Multiple Myeloma
por: Alhaj Moustafa, Muhamad, et al.
Publicado: (2013)

Acute Acalculous Cholecystitis in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Sunitinib-Induced Acute Interstitial Nephritis in a Thrombocytopenic Renal Cell Cancer Patient
por: Azar, Ibrahim, et al.
Publicado: (2017)

The complexity of sunitinib dosing in renal cell cancer patients
por: Desar, Ingrid M.E., et al.
Publicado: (2012)

Sunitinib re-challenge in advanced renal-cell carcinoma
por: Porta, C, et al.
Publicado: (2014)

Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
por: Mahalingam, D, et al.
Publicado: (2011)

A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma
por: Liman, Andrew D., et al.
Publicado: (2018)

Natural history of multiple myeloma with de novo del(17p)
por: Lakshman, Arjun, et al.
Publicado: (2019)

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
por: Lakshman, Arjun, et al.
Publicado: (2018)

The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib
por: Frees, Sebastian, et al.
Publicado: (2018)

Acute Kidney Failure: When Multiple Myeloma Doesn´t Give Additional Clues
por: Cerqueira, Ana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_il3qc6fiidr470nvan1flsf1r6